Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Privia Health (PRVA) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Privia Health (PRVA) over the last 6 years, with Q3 2025 value amounting to 2.51%.

  • Privia Health's EBITDA Margin rose 11200.0% to 2.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.42%, marking a year-over-year increase of 5900.0%. This contributed to the annual value of 1.04% for FY2024, which is 2700.0% down from last year.
  • As of Q3 2025, Privia Health's EBITDA Margin stood at 2.51%, which was up 11200.0% from 0.68% recorded in Q2 2025.
  • Privia Health's EBITDA Margin's 5-year high stood at 3.84% during Q1 2021, with a 5-year trough of 85.45% in Q2 2021.
  • Its 5-year average for EBITDA Margin is 4.49%, with a median of 0.7% in 2022.
  • As far as peak fluctuations go, Privia Health's EBITDA Margin tumbled by -890600bps in 2021, and later soared by 839800bps in 2022.
  • Quarter analysis of 5 years shows Privia Health's EBITDA Margin stood at 6.92% in 2021, then soared by 110bps to 0.7% in 2022, then crashed by -44bps to 0.39% in 2023, then surged by 205bps to 1.19% in 2024, then surged by 111bps to 2.51% in 2025.
  • Its EBITDA Margin stands at 2.51% for Q3 2025, versus 0.68% for Q2 2025 and 1.13% for Q1 2025.